Omission of SLNB in CN0 Early Breast Cancer

NARecruitingINTERVENTIONAL
Enrollment

311

Participants

Timeline

Start Date

June 21, 2023

Primary Completion Date

July 1, 2027

Study Completion Date

October 1, 2027

Conditions
Breast CancerClinically Assessed Negative Axillary Lymph NodesSentinel Lymph Node
Interventions
PROCEDURE

Omit SLNB

All patients enrolled have to receive two or more imaging tests including axillary ultrasound assessed as axillary lymph node negative, and other tests including MRI, PET-CT, \[18F\]-FDG PET-MRI, axillary surgery will be omitted for eligible patients, and BCS or mastectomy (allowing breast reconstruction) will be chosen voluntarily by the patient under the premise of ensuring therapeutic efficacy, patients receiving BCS must undergo whole breast irradiation (WBI) after surgery, and the radiotherapy target area does not include the axillary region.

Trial Locations (1)

Unknown

RECRUITING

the First Affiliated Hospital of Nanjing Medical University, Nanjing

All Listed Sponsors
lead

The First Affiliated Hospital with Nanjing Medical University

OTHER